Dr. Reddy's Laboratories Limited Capital Reinvestment Ratio
Dr. Reddy's Laboratories Limited capital reinvestment ratio. Dr. Reddy's Laboratories Limited (RDDA) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (€10.91 Billion) in capital expenditures (€7.32 Billion). See Dr. Reddy's Laboratories Limited (RDDA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dr. Reddy's Laboratories Limited (2017–2025)
Capital reinvestment ratio of Dr. Reddy's Laboratories Limited from 2017 to 2025. This chart tracks Dr. Reddy's Laboratories Limited's Capital Reinvestment Ratio across 9 annual periods. See how financially flexible is Dr. Reddy's Laboratories Limited to measure the company's free cash flow as a share of total liabilities.
Dr. Reddy's Laboratories Limited Capital Reinvestment Ratio by Year (2017–2025)
Dr. Reddy's Laboratories Limited capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see how efficiently does Dr. Reddy's Laboratories Limited generate cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | €46.43 Billion | €34.40 Billion | ▲ +22.7% |
| 2024 | 0.60x | €45.43 Billion | €27.43 Billion | ▲ +88.4% |
| 2023 | 0.32x | €58.88 Billion | €18.87 Billion | ▼ -38.6% |
| 2022 | 0.52x | €28.11 Billion | €14.66 Billion | ▲ +91.2% |
| 2021 | 0.27x | €35.70 Billion | €9.74 Billion | ▲ +68.0% |
| 2020 | 0.16x | €29.84 Billion | €4.85 Billion | ▼ -33.0% |
| 2019 | 0.24x | €28.70 Billion | €6.96 Billion | ▼ -53.0% |
| 2018 | 0.52x | €18.03 Billion | €9.29 Billion | ▼ -9.7% |
| 2017 | 0.57x | €21.51 Billion | €12.28 Billion | — |